BEIJING, Sept. 5, 2014 /PRNewswire/ -- China Biologic
Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a
leading fully integrated plasma-based biopharmaceutical company in
China, is scheduled to participate
in the upcoming conferences:
- Morgan Stanley Global Healthcare Conference, to be held
September 8-10, 2014 at the Grand
Hyatt New York. Management is scheduled to meet with institutional
investors throughout September
9-10.
- Morgan Stanley Asia Pacific Healthcare Day, to be held
September 11, 2014 at the Boston
Harbor Hotel. Management is scheduled to meet with institutional
investors throughout the day.
- Aegis Healthcare & Technology Conference, to be held
September 10-13, 2014 at the Wynn Las
Vegas. Management will present at 1:30
p.m. local time on September
12 and meet with institutional investors throughout the
day.
For additional information, please contact the respective
institutional sales representative at each sponsoring bank.
About China Biologic Products, Inc.
China Biologic is a leading plasma-based biopharmaceutical
company in China. The Company's
products are used as critical therapies during medical emergencies
and for the prevention and treatment of life-threatening diseases
and immune-deficiency related diseases. China Biologic is
headquartered in Beijing and
manufactures over 20 different dosages of plasma-based products
through its indirect majority-owned subsidiaries, Shandong Taibang
Biological Products Co., Ltd. and Guizhou Taibang Biological
Products Co., Ltd. The Company also has an equity investment in
Xi'an Huitian Blood Products Co., Ltd. The Company sells its
products to hospitals and inoculation centers, as well as
distributors, in China. For
additional information, please see the Company's website,
www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: bill.zima@icrinc.com
SOURCE China Biologic Products, Inc.